Lung Tumor Growth Modeling in Patients with NSCLC Undergoing Radiotherapy

被引:3
|
作者
Ghita, Maria [1 ,2 ,3 ]
Chandrashekar, Vasudha [1 ]
Copot, Dana [1 ,2 ]
Billiet, Charlotte [4 ,5 ]
Verellen, Dirk [4 ,5 ]
Ionescu, Clara M. [1 ,2 ,6 ]
机构
[1] Univ Ghent, Res Grp Dynam Syst & Control, B-9052 Ghent, Belgium
[2] Flanders Make Consortium, EEDT Core Lab Decis & Control, B-9052 Ghent, Belgium
[3] Canc Res Inst Ghent, B-9052 Ghent, Belgium
[4] Iridium Canc Network GZA Hosp Sint Augustinus, Dept Radiat Oncol, B-2610 Antwerp, Belgium
[5] Antwerp Univ, Dept Radiotherapy, Fac Med & Hlth Sci, B-2610 Antwerp, Belgium
[6] Tech Univ Cluj Napoca, Dept Automat Control, Cluj Napoca 400114, Romania
来源
IFAC PAPERSONLINE | 2021年 / 54卷 / 15期
关键词
Mathematical modeling; lung cancer; stereotactic body radiation therapy; tumor dynamics; fractional calculus; CANCER;
D O I
10.1016/j.ifacol.2021.10.261
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
This paper proposes two modeling approaches to predict lung tumor dynamics as an effect of radiotherapy. Real clinical information of non-small cell lung cancer (NSCLC) patients undergoing stereotactic body radiation therapy (SBRT) as the primary treatment method has been used for numerical simulations. The classical Gompertz model for tumor volume growth prediction was modified using a fractional parameter and combined with the linear-quadratic model to foresee the effect of SBRT on the targeted tumor. Another approach was implemented by following a pharmacokinetic-pharmacodynamic (PKPD) minimal compartmental model for single therapy with SBRT. Statistical analysis has been carried out to compare the two models. In terms of tumor growth prediction, obtained results indicated a decrease in the total tumor volume for both modeling approaches. A striking observation to emerge from the data comparison is the interesting perspective of fractional tools for further exploration in modeling tumor growth. Copyright (C) 2021 The Authors.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 50 条
  • [31] Whole Tumor Perfusion CT in Patients with NSCLC Treated with Endostar Combined with Concurrent Radiotherapy
    Shi, Lei
    Chen, Ming
    Shao, Guo-Liang
    Xu, Yu-Jin
    Sun, Jing-Jing
    Wang, Xu
    Huang, Jie-Hui
    Liu, Bo
    Ma, Hong-Lian
    Long, Dan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S578 - S579
  • [32] Impact of positive pleural lavage cytology on survival in patients undergoing lung resection for NSCLC
    Lim, E.
    Clough, R.
    Goldstraw, P.
    LUNG CANCER, 2009, 63 : S17 - S17
  • [33] Tumor blood supply evaluation for NSCLC radiotherapy planning
    Szluha, K.
    Lazanyi, K.
    Simon, M.
    Abramyuk, A.
    Tokalov, S.
    Wolf, G.
    Appold, S.
    Herrmann, T.
    Abolmaali, N.
    EJC SUPPLEMENTS, 2009, 7 (03): : 14 - 14
  • [34] Precision radiotherapy by SPECT lung functional imaging in NSCLC
    Greco, Carlo
    Fiore, Michele
    Valenza, Venanzio
    Di Venanzio, Cristina
    Rovera, Guido
    Ippolito, Edy
    Zollino, Mariella
    D'Angelillo, Rolando Maria
    Giordano, Alessandro
    Ramella, Sara
    JOURNAL OF MENS HEALTH, 2022, 18 (04)
  • [35] CYTOKINE LEVELS IN PEDIATRIC-PATIENTS WITH BRAIN-TUMOR UNDERGOING RADIOTHERAPY
    GRIDLEY, DS
    ARCHAMBEAU, JO
    LOREDO, LN
    BEDROS, AA
    ANDRES, ML
    SLATER, JM
    FASEB JOURNAL, 1995, 9 (03): : A536 - A536
  • [36] Prevalence of and Risk Factors for Emotional Distress in Patients Undergoing Radiotherapy for Lung Cancer
    Rades, Dirk
    Al-salool, Ahmed
    Bohnet, Sabine
    Yu, Nathan Y.
    ANTICANCER RESEARCH, 2023, 43 (05) : 2111 - 2118
  • [37] A Framework to Determine the Risk of Developing Pneumonitis in Lung Cancer Patients Undergoing Radiotherapy
    Chawla, A.
    Das, S.
    MEDICAL PHYSICS, 2010, 37 (06) : 3349 - +
  • [38] Coordinating care and management of lung cancer patients undergoing concurrent chemotherapy and radiotherapy
    Gardener, T.
    LUNG CANCER, 2012, 75 : S35 - S35
  • [39] REQUITE multicentre study of patients undergoing radiotherapy for breast, lung or prostate cancer
    West, C.
    Azria, D.
    Chang-Claude, J.
    De Ruysscher, D.
    Elliott, R.
    Gutierrez-Enriquez, S.
    Rancati, T.
    Rosenstein, B.
    Seibold, P.
    Talbot, C.
    Vega, A.
    Veldeman, L.
    Webb, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S895 - S895
  • [40] Avoiding cardiac toxicity in patients undergoing curative intent radiotherapy for lung cancer
    Banfill, K.
    Sun, F.
    Mcwilliam, A.
    Abravan, A.
    Lilley, J.
    Wheller, R.
    Falk, S.
    Schmitt, M.
    Van Herk, M.
    Franks, K.
    Faivre-Finn, C.
    LUNG CANCER, 2019, 127 : S91 - S92